SCHEDULE: Madison Avenue Partners Discloses 5.8% Stake in STAAR

Madison Avenue Partners and affiliated entities have reported a 5.8% beneficial ownership stake in STAAR Surgical Co.

Summary

• A group of investment entities led by Eli Samaha has filed a Schedule 13G, reporting beneficial ownership of 2,854,710 shares of STAAR Surgical Co. common stock.
• This holding represents approximately 5.8% of the company's total outstanding common stock, based on 49,512,749 shares outstanding as of February 27, 2026.
• The reporting group includes Madison Avenue International LP, Madison Avenue Partners, LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC, and Eli Samaha.
• The filing indicates that these shares are held for investment purposes and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive development, as it reflects institutional interest in the company's equity without indicating any immediate activist pressure or strategic shifts.

Positives

• The acquisition of a 5.8% stake by an institutional investment group signals confidence in the long-term value of STAAR Surgical Co.

Negatives

• None identified in this passive investment disclosure.

Risks

• The filing notes that the securities were not acquired for the purpose of changing or influencing control, which limits the immediate strategic impact of this ownership.

Future Outlook

The reporting persons state that the securities are held for investment purposes and do not currently intend to influence the control of the issuer.

Industry Context

StockSavvy.ai notes that the entry of institutional investors like Madison Avenue Partners into the ophthalmic medical device sector often reflects a positive outlook on the growth potential of companies like STAAR Surgical, which specializes in implantable lenses.

Comparison to Industry Standards

• The 5.8% stake is a standard threshold for institutional disclosure, consistent with typical passive investment activity in the medical device industry.

Stakeholder Impact

• Shareholders may view the accumulation of a 5.8% stake by a dedicated investment group as a validation of the company's market position.

Next Steps

• The reporting group will be required to file amendments to this Schedule 13G if there are material changes in their percentage of ownership.

Key Dates

Keywords

STAAR Surgical, Schedule 13G, Institutional Ownership, Eli Samaha, Madison Avenue Partners, Beneficial Ownership